Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
94%
OVERLAP
BY WEIGHT
36
# OF OVERLAPPING
HOLDINGS
EXV4.DE
60
HOLDINGS
80%
ALSO IN ESIH.L
ESIH.L
48
HOLDINGS
100%
ALSO IN EXV4.DE
SECTOR DRIFT (EXV4.DE minus ESIH.L)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in EXV4.DE |
Weight in ESIH.L |
Overlap | |
|---|---|---|---|---|
 |
ROCHE HOLDING AG-BR | 15.1% | 16.5% | 15.1% |
 |
ASTRAZENECA PLC | 13.8% | 14.3% | 13.8% |
|
NOVARTIS AG | 13.7% | 14.1% | 13.7% |
 |
NOVO NORDISK A/S-B | 9.3% | 9.7% | 9.3% |
 |
SANOFI-AVENTIS | 5.2% | 5.2% | 5.2% |
EXV4.DE Overweight Relative to ESIH.L
|
NOVOZYMES A/S-B SHARES | 1.1% |
|
CONVATEC GROUP PLC | 0.3% |
 |
GETINGE AB-B SHS | 0.2% |
|
ZEALAND PHARMA A/S | 0.2% |
|
CAMURUS AB | 0.2% |
|
TECAN GROUP AG-REG | 0.1% |
|
AMBU A/S CLASS B | 0.1% |
|
BAVARIAN NORDIC A/S | 0.1% |
|
COLOPLAST A/S CLASS B | 0.1% |
 |
AMPLIFON SPA | 0.1% |
EXV4.DE Underweight Relative to ESIH.L
|
ROCHE HOLDING AG-BR | -1.3% |
|
ASTRAZENECA PLC | -0.5% |
|
NOVARTIS AG | -0.5% |
|
NOVO NORDISK A/S-B | -0.4% |
|
GSK PLC | -0.2% |
 |
UCB SA | -0.1% |
 |
BAYER AG | -0.1% |
 |
ARGEN-X SE | -0.1% |
|
LONZA GROUP AG-REG | -0.1% |
|
FRESENIUS SE | -0.1% |